BDPT logo

BioAdaptives, Inc. Stock Price

OTCPK:BDPT Community·US$54.0k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

BDPT Share Price Performance

US$0.0048
-0.07 (-93.18%)
US$0.0048
-0.07 (-93.18%)
Price US$0.0048

BDPT Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk with weak fundamentals.

6 Risks
0 Rewards

BioAdaptives, Inc. Key Details

US$23.8k

Revenue

US$7.2k

Cost of Revenue

US$16.6k

Gross Profit

US$1.5m

Other Expenses

-US$1.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-0.12
69.81%
-6,186.31%
-21.4%
View Full Analysis

About BDPT

Founded
2013
Employees
1
CEO
James Keener
WebsiteView website
www.shopbioadaptives.com

BioAdaptives, Inc. investigates, markets, and distributes natural plant, fungi, and algal-based products and medical devices for humans and animals. The company offers MyndMed for immediate cognitive enhancement, medium-term resilience and memory gains, and long-term neuroprotection and cognitive health; Zeranovia, a weight loss enhancer; Wynovia to help reduce the loss of lean muscle mass during dieting; and Xcellara, a regenerative wellness solution. It also provides canine products under the PawPa brand; dog chew products under the Regen brand; and Lung Flute, a medical device. The company was formerly known as APEX 8 Inc. and changed its name to BioAdaptives, Inc. in September 2013. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada.

Recent BDPT News & Updates

Recent updates

No updates